Profile
Presently, Zheru Zhang is President & Director at I-Mab and President for I-Mab Biopharma (Shanghai) Co., Ltd. (a subsidiary of I-Mab). In his past career Dr. Zhang was Chief Executive Officer at Shanghai Jmt Bio Co. Ltd., Vice President-Research & Development for Celltrion, Inc. and President at I-Mab Bio-tech (Tianjin) Co., Ltd. Dr. Zhang received a graduate degree from Soochow University and a doctorate from the University of Alberta.
Former positions of Zheru Zhang
| Companies | Position | End |
|---|---|---|
| I-MAB | President | 2022-08-30 |
I-Mab Bio-tech (Tianjin) Co. Ltd.
 I-Mab Bio-tech (Tianjin) Co. Ltd. BiotechnologyHealth Technology I-Mab Bio-tech (Tianjin) Co., Ltd. engages in the research and development of medicine and biological products. Its business activities include investment information consultation, and health information services. The company was founded on April 19, 2012 and is headquartered in Tianjin, China. | President | 2017-03-31 |
| Shanghai JMT-BIO Technology Co., Ltd. | Chief Executive Officer | 2015-09-30 |
| CELLTRION, INC. | Chief Tech/Sci/R&D Officer | 2012-09-30 |
I-MAB Biopharma Co., Ltd.
 I-MAB Biopharma Co., Ltd. BiotechnologyHealth Technology I-Mab Biopharma (Shanghai) Co., Ltd. engages in the development of biologics. It focuses on monoclonal antibodies or bi-specific antibodies in the areas of immuno-oncology and autoimmune diseases. The company was founded by Jingwu Zang in March 2017 and is headquartered in Shanghai, China. | President | - |
Training of Zheru Zhang
| Soochow University | Graduate Degree |
| University of Alberta | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| I-MAB | Health Technology |
| CELLTRION, INC. | Health Technology |
| Private companies | 3 |
|---|---|
I-MAB Biopharma Co., Ltd.
I-MAB Biopharma Co., Ltd. BiotechnologyHealth Technology I-Mab Biopharma (Shanghai) Co., Ltd. engages in the development of biologics. It focuses on monoclonal antibodies or bi-specific antibodies in the areas of immuno-oncology and autoimmune diseases. The company was founded by Jingwu Zang in March 2017 and is headquartered in Shanghai, China. | Health Technology |
I-Mab Bio-tech (Tianjin) Co. Ltd.
I-Mab Bio-tech (Tianjin) Co. Ltd. BiotechnologyHealth Technology I-Mab Bio-tech (Tianjin) Co., Ltd. engages in the research and development of medicine and biological products. Its business activities include investment information consultation, and health information services. The company was founded on April 19, 2012 and is headquartered in Tianjin, China. | Health Technology |
| Shanghai JMT-BIO Technology Co., Ltd. |
- Stock Market
- Insiders
- Zheru Zhang
